Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Biospecimen Resource for Pancreas Disease, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00830557

Enrollment

20000

Registered

2009-01-28

Start date

2000-10-01

Completion date

2027-08-30

Last updated

2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis, Chronic Pancreatitis, Hereditary Pancreatitis, Islet Cell Tumor, Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Disease, Pancreatic Neuroendocrine Carcinoma

Keywords

recurrent pancreatic cancer, stage I pancreatic cancer, stage II pancreatic cancer, stage III pancreatic cancer, stage IV pancreatic cancer, recurrent islet cell carcinoma, pancreatic alpha cell carcinoma, pancreatic beta islet cell carcinoma, pancreatic delta cell carcinoma, pancreatic G-cell carcinoma

Brief summary

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.

Detailed description

PRIMARY OBJECTIVE: I. To maintain a resource (bank) of biospecimens and data collected from individuals being seen clinically for pancreas conditions to facilitate the discovery and development of (but not limited to) biomarkers of risk (including genomic and proteomic) and early detection as well as novel targeted therapies for pancreatic diseases with a focus on pancreatic cancer. OUTLINE: This is an observational study. Patients undergo blood, saliva, and previously obtained leftover tissue sample collection on study. Patients also complete questionnaires and have their medical records reviewed on study.

Interventions

OTHERmedical chart review

baseline, 12 month and 36 months

OTHERsurvey administration

baseline, 6 month, 12 month

OTHERbiospecimen collection

baseline

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Known or suspected pancreas disease including: * pancreas adenocarcinoma * islet cell cancer * pancreatic cysts * pancreatitis (hereditary, acute, or chronic) * Next of kin of deceased participant who did not complete participation before passing away

Exclusion criteria

* Under the age of 18 * Unable to provide informed consent * Prison inmates

Design outcomes

Primary

Measure	Time frame
Collection of clinical data, health and family histories by survey	baseline enrollment, 6 months, 12 months
Collection of blood and/or tissue, fecal and oral specimens	baseline
Collection of information regarding food preparation and intake by survey	baseline

Countries

United States

Contacts

CONTACTAdriana Delgado, MA

pancreas@mayo.edu800-914-7962

CONTACTHeather M Streich, CCRP

pancreas@mayo.edu800-914-7962

PRINCIPAL_INVESTIGATORShounak Majumder, MD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026